ALPS Advisors »

Taysha Gene Therapies shares owned by ALPS Advisors

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 225k 5.50

More positions owned by ALPS Advisors

Western Midstream Partners L Com Unit Lp Int (WES)
Energy Transfer Com Ut Ltd Ptn (ET)
Enterprise Products Partners (EPD)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Usa Compression Partners Com Unit Ltdpar (USAC)
Genesis Energy Unit Ltd Partn (GEL)
Cameco Corporation (CCJ)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Global Partners Com Units (GLP)
Uranium Energy (UEC)
Delek Logistics Partners Com Unt Rp Int (DKL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for ALPS Advisors

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies